CEO Healthcare Symposium
Anthony Spero has more than 20 years of experience in healthcare operations and business development within the acute and post-acute health care industry. As an operator in the post-acute space Mr. Spero has managed Skilled Nursing and Long Term Care Facilities, Independent and Assisted Living Facilities, CCRC’s and Long Term Acute Care Hospitals. Currently as President of Ascend Health, he leads the company’s multi-state operation focused on providing best-in-class hospice, home health and concierge home care services. Previously, Mr. Spero worked as the National Vice President of Business Development at Golden Living. Mr. Spero received his Master’s Degree in Healthcare Administration and his MBA in Finance from Suffolk University. He is a licensed nursing home administrator and is most proud of his employment as a certified nursing assistant completed very early on in his healthcare career. In 2015 Mr. Spero was a speaker at the AHCA Quality Symposium and the Home Care Leadership Summit and presented on the topic of “People Centered Care”.
Dr. Ashok Rai is President and CEO of Prevea Health, the largest multi-specialty group practice in
northeast Wisconsin. Dr. Rai has a personal commitment to the wellness of this community and
continues to inspire others to live healthy. His association with Prevea Health began in 2001 when he joined Prevea’s partner hospital, HSHS St. Mary’s Hospital as the Medical Director for Hospitalist
Services. During the past 16 years, Dr. Rai has also served as St. Mary’s Physician Quality Director and
Prevea’s Associate Medical Director of Operations, Senior Vice President, and Chief Medical Officer. Dr.
Rai’s passion to redesign healthcare extends nationally, and he was recently named as the Chair Elect for the Board of Directors of the AMGA—a national association of medical groups leading the
transformation of health care in America. His passion for wellness has led Prevea to embrace the Patient
Centered Medical Home model of care, bringing patient-centric care beyond the clinic and directly out
into the community and workplace. Prevea’s customized care educates and empowers individuals to lead a healthy and fit lifestyle, thereby improving the total wellness of the region.
Benjamin Edmands is a Managing Partner and Co-Founder of Consonance Capital Partners. Prior to founding CCP, he was a Managing Director at JPMP, where he co-led the Healthcare Group. Benjamin joined JPMP in 1993 and served on numerous boards, including Big Rock, CareMore, DJO, LHP Hospital Group, MedQuest, National Surgical Care, and Warner Chilcott, Inc. He also serves on the board of Enclara Pharmacia, Bako Integrated Physician Solutions, Mount Sinai’s Children’s Environmental Health Center and is on the Executive Council of the Harvard School of Public Health. Benjamin holds a BA from Colgate University and an MBA from Columbia Business School.
Dr. Brunn was appointed in January 2017 to lead Bayer’s Pharmaceuticals business in the United States, Canada, and Latin America and is an executive member of the Country Council.
Over the last 25 years, he has held a number of senior leadership positions in Europe, Asia and the United States at leading companies such as Eli Lilly, Novartis and Bausch and Lomb. Most recently, he was Head of Bayer Pharmaceuticals Commercial Operations in Japan where he achieved double-digit growth that led to Bayer being recognized as one of the top 10 pharmaceutical companies in Japan for the first time in 26 years. He also served as the Chairman of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan, an organization representing 24 R&D based innovative pharmaceutical companies in Japan. Dr. Brunn joined Bayer Pharmaceuticals in China in 2011 to lead the Global Primary Care business.
Dr. Brunn started his career at Eli Lilly and Company, where he held a variety of managerial positions in sales and marketing in the United States. He is passionate about meeting the needs of customers and patients and has a proven track record for building the right internal culture to drive business growth.
Dr. Brunn graduated from the University of Freiburg in Germany with a Master of Science in Pharmaceutical Science. In addition, he studied at the University of Washington under a research scholarship. He received his PhD in Chemistry from the University of Hamburg, Germany and completed his executive education at London Business School.
Born in Tuebingen, Germany, Dr. Carsten Brunn is married with one son.
Charles P. Theuer, M.D., Ph.D. – Director, President and Chief Executive Officer – Dr.
Theuer has been CEO and President of TRACO, and a Director of TRACON Pharmaceuticals
(NASDAQ: TCON) since 2006. Prior thereto, from October 2004 to July 2006, Dr. Theuer was
Chief Medical Officer at TargeGen Inc., where he led the development of small molecule kinase
inhibitors in oncology (including fedratinib, a jak2 inhibitor), ophthalmology and cardiovascular
disease. From October 2003 to October 2004, Dr. Theuer was the Director, Clinical Oncology at
Pfizer, where he led the clinical development of Sutent® (sunitinib maleate) in kidney cancer;
Sutent® was approved by the U.S. Food and Drug Administration in January 2006 for treating
advanced kidney cancer. Prior thereto, Dr. Theuer held senior positions at IDEC
Pharmaceuticals, from June 2002 to October 2003, and the National Cancer Institute developing
other agents, including small molecules and monoclonal antibody therapies. Dr. Theuer holds a
B.S. degree from the Massachusetts Institute of Technology, an M.D. degree from the University
of California, San Francisco and a Ph.D. degree from the University of California, Irvine. He
completed a residency in general surgery at Harbor-UCLA Medical Center and was Board
Certified in general surgery in 1997. Dr. Theuer held academic positions at the National Cancer
Institute (NCI) and at the University of California, Irvine, where he was a member of the Division
of Surgical Oncology. His previous research involved immunotoxin and cancer vaccine
development, translational work in cancer patients, as well as gastro-intestinal cancer
Ms. Cindy Bo has worked in healthcare strategy for over 20 years, ranging across the provider, payor and life sciences sectors.
She is named by the Becker's Hospital Review in 2016 and 2015 as one of the top 130 women hospital and health system
leaders to know in the United States.
Ms. Bo has expertise in strategic planning, business development, mergers and acquisitions and finance transformation. She has
worked collaboratively with executive leaders across the healthcare industry to improve the viability of healthcare delivery and
management of population health. Currently, she is the Chief Strategy & Business Development Officer for Nemours Children’s
Health System, Alfred I. duPont Hospital for Children. At Nemours, she manages the strategies and business development
processes in support of new growth and integration opportunities for both the hospital and practice in the Delaware Valley. She
also develops new strategic partnerships with clinical partners and other healthcare vendors. Ms. Bo drives the business
planning process for clinical services and programs. She is also co-leading the Nemours Value-Based Services Organization, as
Nemours transitions to value.
Prior to joining Nemours, she was a Senior Manager and an Ellen Gabriel Fellow at Deloitte, in the Healthcare M&A Practice. At
Deloitte, she led the strategic transformation for large regional health systems; led the M&A deals for national and regional
health plans, health systems and pharmacy benefit managers; and led revenue cycle management for major provider systems
around the US. Ms. Bo was also a Director at Novartis, leading the Business Planning & Analysis, Center of Excellence where she
managed the strategic planning for Novartis’ North American Primary Care portfolio.
Ms. Bo is a Malcolm Baldrige Executive Fellow and a graduate of the Disparities Leadership Program, working with
Massachusetts General Hospital. She is also an Aspen Institute Scholar. She is also an appointed Member by Governor John
Carney on the Delaware Economic and Financial Advisory Council. Ms. Bo is currently serving on several distinguished Boards.
She is a Board Member for the Clinic for Special Children in Strasburg, PA, the American Lung Association for the Mid-Atlantic
and the Delaware Center for Health Innovation. She is an Executive Team Member of the United Way of Delaware Young
United Professionals. She currently volunteers for the Nemours Children’s Health System, Alfred I. duPont Hospital for Children
and the Ronald McDonald House of Delaware. In the past, she has volunteered for City Year in Philadelphia, PA; Dekalb
Community Service Board in Atlanta, GA; and The William J. Clinton Foundation in New York, NY.
On the personal side, she is an avid runner, writes children’s stories, creates greeting cards and enjoys spending time with her
husband, David, and sons, Matthew (age 18) and Lucas (age 4).
Ms. Bo has earned her MBA, with high distinction and honors, from Columbia Business School and her BS, summa cum laude,
from Binghamton University School of Management.
Dan Hirschfeld is President of Genesis Rehab Services (RHS)/Respiratory Health Services (RHS)/International Operations and GRS Academy as well as Executive Vice President and Co-Chief Operating Officer for Genesis HealthCare.
Prior to joining Genesis, Dan held President and CEO/COO positions with several privately held and publicly held companies with operations throughout the United States. Dan serves on the Board of Directors for The National Association for the Support of Long Term Care (NASL), the Board of Trustees for Harcum College, the Board of Directors for Argentum (previously Assisted Living Federation of America, ALFA) and Commissioner for the Senior Living Certification Commission
Dan holds a Bachelor of Arts degree with a concentration in accounting from Duke University, and both Masters of Business Administration and Masters of Finance degrees from Loyola College of Maryland.
Daniel Blum has served as President and CEO of Phelps Memorial Hospital Center since December 2014. Prior to joining Phelps as Senior Vice President in 2009, Mr. Blum served as Senior Vice President of White Plains Hospital Center, Vice President of Operations of Stellaris Health Network, and Operations Manager at St. Vincents Hospital and Medical Center in New York City. Mr. Blum began his healthcare career as a paramedic and paramedic instructor in New York City and worked at several New York City hospitals in a clinical and administrative capacity. Mr. Blum holds a bachelors degree in philosophy and a masters degree in healthcare administration, both from New York University. He is a member of the American College of Healthcare Executives and Medical Group Management Association. Mr. Blum is also Chairman of the NYS Department of Health Emergency Medical Advisory Council. Mr. Blum serves as collaborating administrative executive on Phelps Graduate Medical Education Committee and Chairman of the hospitals affiliated child care center.
Dan Murrey is an Orthopedic Spine Surgeon and CEO of Transformant Healthcare solutions (THS).
Dan previously served as CEO of OrthoCarolina, one of the largest orthopedic practices in the country with 160 physicians and 1400 employees throughout the Piedmont of western North Carolina. As CEO, he led efforts in quality improvement, data management, corporate compliance, customer service and contracting innovation. He is also an active researcher and educator, and is a patent-holder and developer of multiple spine care devices.
Transformant Healthcare Solutions (THS) is a management services company that partners with independent physician practices in order to transform the delivery and financing of healthcare, bringing a platform to lower cost of care, improve patient outcomes and enhance the patient experience.
In addition to his role as a physician leader, Dan serves on a number of nonprofit and healthcare boards and speaks about healthcare transformation throughout the country.
David Berry joined Flagship in 2005 where he focuses on innovating, entrepreneuring, and investing in new ventures in life sciences and sustainability. He is a founder of Flagship portfolio companies Joule Unlimited, Eleven Biotherapeutics (NASDAQ: EBIO), Seres Therapeutics (NASDAQ: MCRB), Pronutria Biosciences, LS9 (acquired by Renewable Energy Group) and Indigo. Prior to Flagship, David received an MD from Harvard Medical School and a PhD from the MIT Biological Engineering Division, working in the laboratories of Professors Ram Sasisekharan and Bob Langer, completing the dual degree in just over 5 years.
David currently serves on the Leadership Council of the United Nations Sustainable Development Solutions Network. He is currently on the Boards of the Hackley School and the Juventas New Music Ensemble, and has served on the MIT Corporation, its Board of Trustees as well as the Boston Philharmonic Orchestra. David was elected a 2014 Young Global Leader by the World Economic Forum.
Previously, David was named the Innovator of the Year by Technology Review, and received the prestigious Lemelson-MIT Student Prize for invention and innovation. He was also selected by the US State Department as 1 of 12 Innovators Helping to Reshape Reality.
Douglas Fambrough is a co-founder of Dicerna Pharmaceuticals and joined the company as CEO in May 2010. Prior to joining Dicerna, Dr. Fambrough spent over a decade as a biotechnology venture capitalist with Oxford Bioscience Partners, one of Dicerna’s investors. At Oxford, he specialized in financing innovative life science technology companies such as the first generation RNA interference company, Sirna Therapeutics (acquired by Merck). Among his other investments are high-throughput DNA sequencing pioneer Solexa (acquired by Illumina); Xencor, which engineers antibody Fc domains to enhance drug properties; Rib-X Pharmaceuticals, a developer of antibiotics against multi-drug resistant pathogens; and Solstice Neurosciences (acquired by US WorldMeds). Prior to Oxford, Dr. Fambrough was a genomic scientist at the Whitehead/MIT Center for Genome Research (now known as the Broad Institute). Dr. Fambrough graduated from Cornell University and holds a Ph.D. in genetics from the University of California, Berkeley.
Gary Cohen is Executive Vice President and President, Global Health and Development
at BD (Becton, Dickinson & Co). Mr. Cohen is also a board director of the Perrigo
Company, CDC Foundation and UNICEF USA, board co-chair of GBCHealth, and board
chair/founder of Together for Girls. He previously served on the UN Commission on
Life Saving Commodities for Women and Children and presently serves on the Scientific
Advisory Board of Grand Challenges Canada.
Mr. Cohen and BD engage in extensive cross-sector collaboration to address unmet
health needs globally, working with international agencies, governments and non-
government organizations, focused on specific health goals such strengthening clinical
and laboratory practices, safely immunizing children, addressing infectious and non-
communicable diseases, reducing maternal and newborn mortality, combating
antimicrobial resistance and improving safety for health workers and patients. He
frequently serves as an expert speaker and advocate on advancing health and human
rights, in various venues including the United Nations, Vatican, World Bank, World
Health Assembly, U.S. Department of State and World Economic Forum-Davos. He has
been honored for his humanitarian work by MESAB (Medical Education for South
African Blacks), B’nai B’rith International, UNICEF USA, the Dikembe Mutombo
Foundation, the American Jewish Committee and the Nymbani Home for HIV positive
children in Kenya. Mr. Cohen holds B.A. and an M.B.A. degrees from Rutgers
University and previously served on the university’s board of trustees. In 2016 he was
named a Rutgers 250 Fellow in association with the university’s 250 th anniversary.
Glen Tullman is the Chairman and Chief Executive Officer of Livongo Health. Livongo is empowering people with chronic conditions, beginning with diabetes, to live better lives, using a combination of innovative technology paired with personalized and context sensitive information delivered when and where it is most impactful at improving health. Today, Livongo is the leading consumer digital health company focusing on chronic conditions.
A visionary leader and entrepreneur, Tullman previously ran two public companies that changed the way healthcare is delivered. Most recently, he served as Chief Executive Officer of Allscripts (NASDAQ: MDRX), the leading provider of Electronic Health Records, Practice Management and Electronic Prescribing systems, where he grew revenues from $30 million in 1997 to more than $1.4 billion in 2012, and led the company’s IPO and secondary offerings. Prior to Allscripts, Tullman was CEO of Enterprise Systems, a leading healthcare-information services company providing resource-management solutions to large, integrated healthcare networks that he also took public before it was sold to McKesson HBOC (NYSE: MCK).
Tullman is also a successful entrepreneur, and Co-Founder and Partner in 7wireVentures, a Chicago-based investment firm focused on healthcare and education. Through 7wire, he has co-founded a number of ventures including one of the country’s leading solar energy companies, SoCore Energy, sold to Edison Ventures, and a digital education company, and holds investments in several ventures focused on mobile and cloud-based health solutions.
As a recognized leader in healthcare and entrepreneurship, Glen is a regular contributor to Forbes, and sought after as a speaker and industry expert on innovation and change. A strong proponent of philanthropy, he serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation.
Gregory Solometo co-founded Alliance Homecare in 2006 and serves as the Chief Executive Officer where he oversees the day-to-day operations and strategy. Gregory started the company after he took care of his grandmother for five years when she was suffering from Alzheimers and created The Grandma Rule? hiring philosophy. Gregorys firsthand experience of searching for caregivers showed him that there were limited resources that met his high level of standards of client care and customer satisfaction. Since that time, Gregory has been committed to providing all clients with an elite and highly qualified team of healthcare professionals that exceed industry standards. Prior to starting Alliance Homecare, Gregory has worked primarily in the financial services industry. Most recently, he worked as a Lean Process Engineer at Deutsche Bank where he provided strategic consulting services to various divisions of the Investment Banking structure and its operations in the US and abroad. Gregory graduated from Emory University in 1995.
Imran Andrabi, MD, is president and chief executive officer of ThedaCare®, a community health system consisting of seven hospitals, 32 clinics and related services across nine counties in Northeast Wisconsin.
Dr. Andrabi joined ThedaCare in 2017 with extensive experience leading safe, quality healthcare in the Midwest. He is passionate about process improvement and providing world-class experiences and care for patients and the caregivers who serve them. He believes in team-based care and innovative design and delivery of this care. Dr. Andrabi characterizes himself as an entrepreneur and clinician who is always looking for next-generation solutions in healthcare delivery.
Dr. Andrabi is a family medicine physician who graduated from King Edward Medical College in Lahore, Pakistan. He completed his transitional year residency and then his family medicine training at Mercy Hospital in Toledo, Ohio, where he served as chief resident. He is board certified by the American Board of Family Medicine and American College of Managed Care Medicine and is a fellow of the American Academy of Family Physicians.
Before joining ThedaCare, Dr. Andrabi was chief operating officer and then president and CEO of Mercy Health in Toledo, Ohio.
He was integrally involved with physician partnerships; growing the clinically integrated network, accountable care organization and physician group; and creating access and business development opportunities in the region. He was instrumental in starting two free standing emergency departments in the region, developed a comprehensive cancer center in partnership with a large group of oncologists and radiation oncologists, and developed ambulatory centers
with diagnostic and therapeutic capabilities in the region.
In addition, while with the Mercy Health system, Dr. Andrabi served as chief operating officer of a 350-bed hospital, chief operating officer and then CEO of a 450-bed Level 1 trauma and regional referral center, president of the Mercy Physician Group and president of the Clinically Integrated Network, and chief network integration officer for the region in Toledo. He served as chairman of the board for Mercy Health Physicians across the Mercy Health system, with 1,200 physicians in Ohio and Kentucky, and vice chair of the board of the clinically integrated network Advanced Health Select in Ohio.
Dr. Andrabi has experience as a private practice physician.
Dr. Andrabi has served on the academic faculty in a family medicine residency program and as program director of a family medicine and transitional year residency training program. He has been on the faculty at the Medical College of Ohio and the Ohio University Heritage College of Osteopathic Medicine. He has received numerous teaching awards from the medical residents over the years. He has also served as a designated institutional official at Mercy Health-St. Vincent Medical Center, which sponsors 13 different residencies and fellowship programs.
Dr. Andrabi is married with three children: two grown sons and a daughter. He loves music, traveling, golf (when he can make it), good food and cars.
Mr. Blech, is a renowned biotechnology entrepreneur who, over the past 35 years, has founded and served on the board of companies which have produced major advances in a broad array of diseases, including the diagnosis of chlamydia, herpes, syphilis and HIV, and the treatment of cystic fibrosis, sexual dysfunction, multiple myeloma and many forms of cancer and hematological disease. The companies he established include Celgene Corporation, the world’s leading company in cancer and hematology and has a current market value in excess of $112 billion, ICOS Corporation which developed the drug Cialis and was purchased by Eli Lilly, Nova Pharmaceutical Corporation which developed a new treatment for brain cancer, Gliadel, and was purchased by Johnson and Johnson, Pathogenesis Corporation which developed the leading drug for cystic fibrosis, added 30 years of life to children with that debilitating disease, and was purchased by Chiron, and Genetics Systems Corporation which developed the first rapid accurate diagnostic for chlamydia which enabled millions of babies to be born around the world who could not have been born without wide spread chlamydia testing which Genetics Systems introduced. The company also developed the first accurate test to safe guard the world’s blood supply from the AIDS virus and was purchased by Bristol Myers.
Mr. Blech’s current roles include Founder and Director of Cerecor, Inc., a CNS company, Director of ContraFect Corporation, an infectious disease company, and Vice Chairman of Edge Therapeutics, Inc., a company that treats life-threatening neurological conditions. He is Vice Chairman of Centrexion Corporation, a company with the world’s largest portfolio of non-opioid pain killers, Vice Chairman of X4 Pharmaceuticals, a cancer immunology company, Vice Chairman of Sapience Therapeutics, an oncology company and Vice Chairman of Aridis Pharmaceuticals, a company with a product to treat pneumonia. He also serves as Vice Chairman of WaveGuide Corporation, a company developing the world’s smallest NMR machine, Vice Chairman of Nacuity, an ophthalmology company with a new treatment for retinitis pigmentosa, Vice Chairman of X-VAX Technology, Inc., a company whose mission it is to eliminate Herpes 1 and Herpes 2 through a childhood vaccine and Vice Chairman of Elucida Oncology, Inc., a nanoparticle company whose technology allows surgeons for the first time to see cancers as they remove them.
The trademark of Mr. Blech’s companies is the quality of the people. These companies have been run by the former Chairman of UBS, the former Chairman of Monsanto, the former Chairman of Merck, the former Chairman and CEO of Pfizer, the former President of Shire, the former Present of Baxter International, the Founder and CEO of Acadia, and the founding Chairman of Amgen. On the scientific side there have been seven Nobel laureates and twenty members of the U.S. National Academy of Sciences associated with these companies. Their Boards of Directors have included Bill Gates, the founder of Microsoft, Don Kendall who built Pepsi Co., Walter Wriston, who built the modern Citigroup, Frank Cary who led IBM when it was the leading company in the world, twenty past and present Chairmen and CEOs of Fortune 500 companies, two former U.S. Senators, four former U.S. Cabinet Officers, one former Commissioner of the U.S. Securities and Exchange Commission, one former Supreme Commander of NATO, and one former President of the United States. Collectively, these companies have helped change the face of medicine.
Jacob Chacko brings to Ignyta a broad range of experience with financing, managing, and advising companies in the life sciences field. At Ignyta, Dr. Chacko leads multiple functions including Finance, Accounting, Investor Relations, Communications, Facility Operations, and IT, and has helped lead nearly $500 million in capital raises. Dr. Chacko joined Ignyta in May 2014 from TPG Capital, a global private investment firm with approximately $70 billion of assets under management, where he served as Vice President focused primarily on healthcare and digital media since August 2008. At TPG, Dr. Chacko helped lead teams that successfully completed acquisitions having an aggregate value of over $10 billion. He served on the boards of directors of RentPath and EnvisionRx, was an advisor to the audit committee of Par Pharmaceutical, and was a board observer to IMS Health and Quintiles Transnational. Dr. Chacko previously served on the Board of the Packard Children’s Health Alliance at the Lucile Packard Children’s Hospital Stanford and is Chairperson of the Western Regional Selection Committee for the Marshall Scholarship. Prior to TPG, Dr. Chacko concurrently received his M.D. with AOA honors from UCLA and his M.B.A. with Distinction from Harvard Business School, and was president of his class at both institutions. Prior to this, Dr. Chacko was a consultant serving healthcare clients at McKinsey & Company, a management consulting firm. Dr. Chacko received a M.Sc. in economic and social history from Oxford University, where he was a Marshall Scholar, and a B.A. in biology, B.S. in gerontology, and minor in health policy and management from the University of Southern California, where he graduated as the University Valedictorian.
Jaime Wesolowski was appointed President and Chief Executive Officer of Methodist Healthcare System of San Antonio (Methodist) in 2007. Methodist is a unique partnership with equal ownership between Hospital Corporation of America (HCA – for profit) and Methodist Healthcare Ministries (MHM – not-for-profit). The System employs over 10,000 people in its 27 facilities, has 400 plus volunteers, and over 2,700 physicians hold clinical privileges at the nine Methodist Healthcare hospitals. Methodist has received numerous awards in recent years, including the Texas Hospital Association Bill Astor Award in 2012, the Texas Healthcare Quality Improvement Award in 2012, and the Texas Award for Performance Excellence in 2014, demonstrating the highest level of quality in the state of Texas. Jaime has led the organization in the use of the Malcom Baldrige Framework for Performance Excellence to ensure organizational sustainability, continuous improvement, and a focus on patient driven results. Methodist was recently named a 2016 Top Workplace by the San Antonio Express-News, and three of its hospitals made the list of Modern Healthcare’s “Top 150 Best Places To Work In Healthcare For 2017”.
Jaime earned his Master’s Degree in Healthcare Administration from Xavier University, and his Bachelor’s of Science from Indiana University in Healthcare Administration.
Before joining Methodist, Jaime served as the CEO of Riverside Community Hospital in Riverside, CA from 2003 to 2007. Prior to that, he was the CEO of Oak Hill Hospital in Spring Hill, FL for four years. He also spent ten years as the CEO of Meadowcrest Hospital in New Orleans, LA.
Jaime was inducted into the Studer Group Fire Starter Hall of Fame in 2011, was named the American Hospital Association (AHA) Grassroots Champion for the State of Texas in 2013, and was honored as a Healthcare Hero by the San Antonio Business Journal in October, 2016.
Jaime’s professional affiliations include memberships in the AHA and the Texas Hospital Association (THA) where he served on the Board from 2011-2016. Recently, he was appointed to serve on the Texas Health Improvement Network Advisory Council, a committee of the Office of Health Affairs, Population Health, of The University of Texas System. In addition, he also serves on the THA HOSPAC Board of Governors.
Being a cancer survivor himself, he is an avid supporter of the American Cancer Society and other cancer related organizations. He and his wife, Lori, co-chaired the 2010 American Cancer Society’s Cattle Baron’s Gala, and have remained active with ACS since then. In 2016, he and other Senior Leaders of Methodist, and their spouses, co-chaired the 2016 Cattle Baron’s Gala. Jaime believes his personal experience as a cancer survivor has given him more defined insight and compassion to the physical, emotional, and spiritual needs of patients and their families.
Jaime and Lori have been married for 27 years. They have two children, Ellie, age 21 and Grayson, age 20. His interests include golf, exercising, and a variety of community support activities.
JEFF ALTER is Chief Executive Officer of UnitedHealthcare’s Commercial Group, which is
supported by 12,000 employees serving nearly 30 million consumers. The Commercial Group
manages health benefits for individuals, public sector employers and businesses of all sizes,
including more than half of the Fortune 100 companies. The organization also serves nearly
three million active duty and retired U.S. military personnel and their families in the TRICARE
West Region. Mr. Alter assumed the role of Commercial Group CEO in 2011.
Mr. Alter previously served as the Northeast Regional CEO for UnitedHealthcare. During his
tenure, Mr. Alter strengthened the business by effectively serving employers’ and consumers’
health care needs, building relationships with brokers, government leaders and other
constituents across the Northeast, and developing new and innovative programs and tools. Mr.
Alter previously served as Chief Operating Officer of the Northeast Region.
Prior to joining UnitedHealthcare, Mr. Alter was Vice President of Strategic Financial Planning
for Oxford Health Plans, where he led the company’s financial planning, merger and acquisition
strategy and strategic initiatives. Oxford was acquired by UnitedHealthcare in 2004.
Mr. Alter’s previous roles include seven years as Vice President of Finance and Operations at
Vytra Health Plans and also serving as Manager of Corporate Budgets for Grumman Aerospace
Mr. Alter received a Bachelor of Science in Marketing and a Masters of Business Administration
in Finance from St. John’s University. He serves on the Board of the Long Island Association,
Long Island’s leading business and civic organization, and the Board of Governors of St. John’s
University. Mr. Alter is actively involved with supporting his alma maters, including St. Francis
Jeffrey Wolf is the founder and CEO of Heat Biologics. He was formerly the founder and managing director at Seed-One Ventures, a firm focused on the systematic formation and management of new biomedical companies based upon novel research breakthroughs.
Throughout his career Mr. Wolf has created life science startup companies and actively supported the growth of these companies. Mr. Wolf’s start-ups include Avigen (co-founder and director), a NASDAQ-listed gene therapy company; TyRx Pharma (co-founder and Chairman) which was focused on the development of novel bio-compatible polymers and recently sold to Medtronic; EluSys Therapeutics (founder and CEO), focused on the development of novel antibodies against infectious diseases and GenerationOne (founder and CEO), focused on mobile-based healthcare solutions.
Mr. Wolf received his M.B.A. from Stanford Business School, his J.D. from New York University School of Law and his B.A. from the University of Chicago, where he graduated with honors in Economics.
James E. Shmerling was named President and Chief Executive Officer at Connecticut Childrens Medical Center on October 1, 2015. For over three decades, Dr. Shmerling has served in management roles in childrens hospitals and is nationally recognized as a leader in issues concerning childrens health and wellness. Prior to joining Connecticut Childrens, Dr. Shmerling spent the last eight years as the Chief Executive Officer of Childrens Hospital Colorado, one of the top ranked childrens hospitals in the nation. Before that, he was the Executive Director and Chief Executive Officer of the Monroe Carell Jr. Childrens Hospital at Vanderbilt from 2002 to 2007. He was the Senior Vice President of Methodist Healthcare and President of Le Bonheur Childrens Medical Center from 1995 to 2002, and was Le Bonheurs Chief Operating Officer from 1991 to 1995. He served as the Associate Director of Hospitals at Indiana University Hospitals and Administrator of the James Whitcomb Riley Hospital for Children from 1987 to 1991. Dr. Shmerlings career in childrens hospitals began in the Childrens Hospital of Alabama where he progressed in administrative responsibilities from 1979 to1987, the last of which was as its Associate Administrator. He earned his Bachelor of Science Degree in Health Education from the University of Tennessee in 1976. In 1980, he was awarded a Master of Science Degree in Hospital and Health Administration from the University of Alabama at Birmingham. He earned a Master of Business Administration from Samford University in 1984 and his Doctorate of Health Administration from the Medical University of South Carolina in 1999. Dr. Shmerling is a Fellow in the American College of Health Care Executives (ACHE). He is an adjunct faculty member in the Hospital Administration programs, University of Alabama at Birmingham. Additionally, Dr. Shmerling is active in several national healthcare organizations. Currently he serves as: Board member of the Childrens Hospital Group, Dublin, Ireland Immediate Past Chair of the Board of Childrens Miracle Network Hospitals, Salt Lake City, Utah Immediate Past Chair of the Board of Childrens Hospital Association, Alexandria, VA Chair of the Child Health Patient Safety Organization, Inc., Overland Park, KS, a component entity of the Childrens Hospital Association Chair Elect on the Governing Council of the American Hospital Associations Section for Maternal and Child Health, Washington, D.C. Past Board Chair of the Colorado Regional Health Information Organization (CORHIO), Denver, Colorado Dr. Shmerling is a native of Nashville, Tennessee.
José Baselga is the Physician-in-Chief at Memorial Sloan Kettering Cancer Center (MSK) and
Professor of Medicine at Weill Cornell Medical College. His long standing research interests are
in the development of targeted agents for the treatment of breast cancer and in studying
strategies to overcome mechanisms of resistance, with over 457 peer-reviewed publications to
date. He conducted pivotal laboratory and clinical studies that led to the approval of
trastuzumab, pertuzumab and everolimus, among other therapies. His current work is in
targeting PI3K and deciphering mechanisms of resistance to anti-estrogen therapies. Prior to
MSK, Dr. Baselga was the Chief of the Division of Hematology / Oncology, Associate Director of
the Massachusetts General Hospital Cancer Center and Professor of Medicine at Harvard
Medical School. He was also the Chairman of Medical Oncology and Founding Director of the
Vall d’Hebron Institute of Oncology in Barcelona, Spain. Dr. Baselga is a past President of the
American Association of Cancer Research (AACR), a past President of the European Society
for Medical Oncology, and a past member of the Board of Directors for the American Society of
Clinical Oncology. He is an elected member of the National Academy of Medicine, the
American Society of Clinical Investigation, the Association of American Physicians, and a Fellow
of the AACR Academy. He is a past member of the Editorial Boards of Cancer Cell, Journal of
Clinical Oncology, and Clinical Cancer Research and is the founding editor-in-chief for the
AACR flagship journal Cancer Discovery.
Karen Teitelbaum is the President/Chief Executive Officer at Sinai Health System, an urban, teaching healthcare system comprised of four hospitals, an epidemiological research institute focusing on healthcare disparities, a community institute with over 25 distinct programs, over 800 medical staff members, and 4,000 employees. Focused on the delivery of high quality services in an efficient and cost effective manner, Sinai Health System has achieved national recognition in quality while reducing costs by millions of dollars due to greater efficiency and management of population health. Karen serves on the boards of the Illinois Health and Hospital Association (Nominating and Governing Committee), Women in Health-Life Sciences, the David Lynch Foundation Advisory Council, and has served on the boards of the Metropolitan Chicago Healthcare Council, Family Health Network, the Theraplay Institute, Academy of Managed Care Pharmacy Foundation, and the Young Womens Leadership Charter School. She is a member of the American Hospital Association Task Force on Ensuring Access for Vulnerable Communities, and has been a member of the American Hospital Association Council on Maternal Fetal Health, and chaired the Building Committee for a significant Federally Qualified Healthcare Center. She is a member of the Economic Club of Chicago, The Chicago Network, and the Commercial Club of Chicago. She has been named one of 130 Nonprofit Hospital & Health System CEOs to Know by Becker´s Hospital Review, as well as being named one of the Leaders of Chicago Healthcare by the same publication. Karen has taught both graduate and undergraduate courses in managed care and marketing and strategy for nonprofit organizations, and is a frequently requested national speaker on healthcare delivery topics such as population health management in an urban environment. Karen holds a Masters of Management degree from Northwestern University, Kellogg School of Management.
Kevin B. Churchwell, MD, is the Executive Vice President of Health Affairs and Chief Operating Officer at Boston Childrens Hospital. He provides leadership, direction, integration and oversight for the medical delivery system, while partnering with the Chief Executive Officer on a full range of research, clinical, academic, operational and strategic issues. Prior to joining Boston Childrens Dr. Churchwell was Chief Executive Officer for Nemours/Alfred I. duPont Hospital for Children in Wilmington, DE. As the lead administrator in the Delaware Valley, Dr. Churchwell was actively driving efforts to increase the quality and affordability of care for all children. Under his leadership, the Leapfrog Group recognized Nemours duPont as one of 12 safest childrens hospitals. Dr. Churchwell also served as the CEO and Executive Director for the Monroe Carell Jr. Children's Hospital, part of the Vanderbilt University Medical Center in Nashville, TN. He previously served in several other capacities, including Chief-of-Staff, Medical Director for the Children's Health and Injury Prevention Program, Medical Director for the Pediatric Critical Care Services, and Transport Director. A graduate of Massachusetts Institute of Technology and Vanderbilt Medical School in Nashville, Dr. Churchwell completed his pediatric residency and a clinical fellowship in Anesthesia and Pediatric Critical Care at Boston Children's Hospital. Since 1993, Dr. Churchwell has been a clinician and faculty member at Vanderbilt University Medical Center. He is a diplomat for the National Board of Medical Examiners and is board certified with the American Board of Pediatrics. Dr. Churchwell was recently appointed the Robert and Dana Smith Associate Professor of Anesthesia at the Harvard Medical School.
Kurt Newman, MD, President and Chief Executive Officer, is a surgeon and recognized leader in pediatric health, nationally and in Washington, DC.
Since becoming CEO in 2011, he has fostered a culture of patient-centered care and championed innovations in research, operations, and clinical care. He has forged productive partnerships with other health systems in the region, with government and community entities and with industry at the local, national, and global level. He is also a strong advocate for expanding mental health access for kids and has led two national forums on this issue.
Dr. Newman joined Children’s National as a surgical fellow in 1984 and became Surgeon-In-Chief and Senior Vice President for the Joseph E. Robert, Jr. Center for Surgical Care in 2003. He was instrumental in developing the vision for the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National, inspired by the bold vision of making surgery for children minimally invasive and pain free. When the Institute was created in 2009 through a transformational $150 Million gift, Dr. Newman served as its Founding Vice President.
Currently, Dr. Newman serves as the Chair of the Children’s Hospital Association Leadership Committee on Advocacy and Policy and as a member of the Board of Trustees. He is also a member of the Board of Directors for the District of Columbia Hospital Association and a member of the Commonwealth Council on Childhood Success in Virginia. In addition, Dr. Newman serves on the Board of the Economic Club of Washington, Greater Washington Board of Trade, Federal City Council, DC Chamber of Commerce, and Fight for Children. Previously, he served as a Board Member of Commissioners of The Joint Commission, a member of the Board of Governors of the American Pediatric Surgical Association, and as Chair of the Surgery Section of the American Academy of Pediatrics.
Dr. Newman is a Professor of Surgery and Pediatrics at the George Washington University School of Medicine and Public Health. He is a graduate of the University of North Carolina at Chapel Hill and received his medical education at Duke University. He completed his surgical residency at the Brigham and Women's Hospital and also served as the Arthur Tracy Cabot Fellow at Harvard Medical School.
In 2017, Dr. Newman’s medical memoir Healing Children: A Surgeon’s Stories from the Frontiers of Pediatric Medicine, debuted as an Amazon Best-Seller in Pediatrics and earned national attention and critical praise in The New York Times Book Review, The Washington Post, and Harvard Business Review.
Dr. Lan Huang is Co-founder, Chairman and CEO of BeyondSpring. Dr. Huang has more than a decade of entrepreneurial experience in the Chinese and U.S. biotechnology industry and invented and holds patents for a number of biotech products for oncology and dermatology indications. In 2009, she was the recipient of China’s “Thousand Talent Innovator Award.”
Prior to founding BeyondSpring, Dr. Huang co-founded Wuxi MTLH Biotechnology Co. Ltd., whose self-designed cancer peptide drug’s China rights were acquired in 2010 by Shanghai Pharmaceutical Group, one of the top three pharmaceutical companies in China. She also co-founded Paramax International, a clinical CRO company in China, which was sold to RPS (a global CRO), then to Warburg Pincus in 2011. In addition, Dr. Huang worked with Forward Ventures, where she led partnering initiatives between Forward’s portfolio companies and Chinese pharmaceutical companies.
Dr. Huang was trained at Memorial Sloan Kettering Cancer Center, where her breakthrough research in solving the first E2-E3 ubiquitin ligase structure involving P53 degradation was published in Science. The immense importance of this field is illustrated by the 2004 award of the Nobel Prize in chemistry to the founders of ubiquitin-mediated protein degradation. She received her Ph.D. in chemistry in four-and-a-half years from the University of California at Berkeley, where she won the graduating Ph.D. woman award from Soroptimist International. Her translational research in cancer signaling pathways involving Ras was published in two Nature papers.
Dr. Kaiser is the leading health sciences executive at Temple University in Philadelphia, PA. He
serves as president and chief executive officer of the Temple University Health System, senior
executive vice-president of Health Affairs, and the Lewis Katz Dean of the Lewis Katz School of
Medicine at Temple University. Prior to joining Temple University, Dr. Kaiser served as
president of the University of Texas Health Science Center at Houston, one of six health-related
campuses of the University of Texas. He graduated from Tulane University School of Medicine
in 1977 and completed his residency in general surgery as well as a fellowship in surgical
oncology at the University of California, Los Angeles. He then completed a residency in
cardiovascular and thoracic surgery at the University of Toronto. Following that, he held
positions as thoracic surgeon at Memorial Sloan-Kettering Cancer Center and assistant professor
of surgery at Cornell University Medical College (New York) and as associate professor at the
Washington University School of Medicine (St. Louis). At the University of Pennsylvania, Dr.
Kaiser held a variety of positions, including chief of general thoracic surgery, founder and
director of the university’s lung transplantation program, and director of its Center for Lung
Cancers and Related Disorders. In 1996, he was named the Eldridge Eliason Professor of
Surgery and, in 2001, was named the John Rhea Barton Professor and chair of the department of
surgery as well as Surgeon in Chief for the University of Pennsylvania Health System.
Dr. Kaiser’s clinical interests include lung cancer, malignant mesothelioma, and mediastinal
tumors. He is the author or co-author of 16 books and more than 300 original papers, and he
serves on multiple editorial boards. Dr. Kaiser has served in a number of leadership capacities
for professional societies and associations and has been a director of the American Board of
Surgery and the American Board of Thoracic Surgery. In 2005, he was elected to the National
Academy of Medicine.
Lois Cormack is the President and Chief Executive Officer of Sienna Senior Living (TSX; SIA), a leading Canadian seniors’ living provider with 71 residences in key markets in Ontario and British Columbia. Sienna’s more than 11,000 employees are passionate about helping residents live fully, every day.
Since joining the company in 2013, Lois has led the organization through significant growth and transformation, more than doubling the size of the company and leading a successful rebranding and repositioning as a high quality provider. Her previous roles include President of Specialty Care, owner of an independent consulting practice and other senior leadership roles in the health care and seniors’ living sectors.
Lois is a respected leader in seniors’ living in Canada who is actively involved with organizations to advocate for sound policy on seniors’ care and services, previously chair of the Ontario Long Term Care Association. She actively supports a number of not-for-profits and charities that support seniors and youth, and currently serves on the Board of Governors at Seneca College.
In 2014 and 2015, Lois was named as one of Canada’s top female entrepreneurs in Profit/Canadian Businesses W100 in recognition for outstanding company growth and performance.
Lois holds a Masters of Health Administration from the University of Toronto and is a graduate of the Ivey Executive Program at University of Western Ontario.
An American success story! Breaking the glass ceiling 32 years ago - after 10 years in clinical practice and 6 years as a Vice President with large chain organizations - Louise, a Registered Nurse with a Masters from the Bloomberg Johns Hopkins School of Public Health founded ACCESS Nursing Services from her apartment in Manhattan, (and no money in her pocket),. Today, ACCESS Nursing enjoys the reputation as a leading regional provider of Clinical Services & Nursing Personnel. “ACCESS” cares for organizations and individuals, from the Bedside to the Boardroom, of large healthcare systems located in NY, NJ and Maryland. ACCESS Nursing is the 3 rd largest female-owned business in New York, and is of the top 3% of successful companies in North America.
Louise considers her “Special Sauce” to be her ability to listen to the client’s problems and develop a clinically strategic Nursing Management & Workforce Solution that provides Better Care at a Lower Cost while keeping Patients and Providers HAPPY!. A mother of 2 living in Westchester, NY - Louise continues to own the company 100% herself and ACCESS’ 10 branches employ over 2,000 caregivers and manages $35 million in Revenues.
No matter what the challenge, Louise is a tough competitor that loves to WIN! Her trophy cabinet contains awards for tennis, golf, skiing, marathon running, boating, hiking, biking and swimming. Weadock believes the required “COMMITMENT to Winning” in business is No Different than in sport! Louise is on the Board of Johns Hopkins School of Nursing and she is considered a thought leader in the area of Pediatric Autism Spectrum Disorders.
Mark L. Wagar, is President of Heritage Medical Systems, an affiliate of the Heritage Provider Network serving over 1 million patient/members in integrated, population based health quality payment programs through medical groups and independent practice associations (IPA’s) in California, New York, and Arizona. He previously served as the President and CEO of Empire BlueCross BlueShield based in New York City and is an Operating Partner with Enhanced Equity Funds which invests exclusively in healthcare services organizations.
Heritage Provider Network (HPN), founded by Dr. Richard Merkin in 1979, is one of the nation’s leading physician-led healthcare solutions organizations. HPN manages one of the largest and most successful Pioneer ACO’s in the United States.
At Empire BlueCross BlueShield, Mr. Wagar led New York’s largest health insurer covering nearly 6 million people, and was a Senior Vice President in WellPoint, Inc. In both Heritage and at Empire, he has been engaged in an active leadership role in public policy, provider collaboration, and community engagement. During his tenure, Empire achieved net growth of over 1 million medical members, market leading member satisfaction results, and the introduction of the first major medical home network in metropolitan New York.
An experienced officer and director in public and private corporations, Mr. Wagar currently serves on the Boards of The New York Academy of Medicine, WhiteGlove, Inc, TurningPoint, and the Tannenbaum Center for Interreligious Understanding. He has been recognized as a Distinguished Alumnus of The Ohio State University, and a recipient of the Dr. Jonas Salk Memorial Mentor in Medicine Award, as well as an honoree helping fund numerous charitable causes supporting healthy communities and diversity. In 1971 he was a member of the Big Ten Champion basketball team of The Ohio State University.
Martha Schram is the President of Aegis Therapies, a position she has held since 2004. Ms. Schram is responsible for the overall leadership and direction of Aegis, including the management of the contract rehabilitation and wellness services Aegis provides to healthcare organizations and the oversight of Aegis growing home health, outpatient and wellness business. Aegis clients include skilled nursing facilities, assisted living facilities, independent living facilities, continuing care retirement communities, home care organizations and individuals utilizing Aegis Medically Oriented Gyms and outpatient rehabilitation services. Prior to becoming President of Aegis, Ms. Schram was a Division Vice President and Group Vice President for Aegis. Her varied and successful career prior to Aegis includes serving as an Area Vice President for NovaCare in Wisconsin; an Executive Director of Rehabilitation Services for Divine Savior Healthcare in Portage, Wisconsin; and Clinical Coordinator for the Veterans Affairs Medical Center in Madison, Wisconsin. Earlier in her career, Ms. Schram held a variety of senior management and leadership positions with increasing responsibility in geriatric healthcare businesses. Ms. Schram earned a Bachelor of Science Degree in Physical Therapy from the University of Colorado at Boulder. She serves on the Board of Directors of the National Association for the Support of Long-Term Care (NASL), and is Chairman of the NASL Medical Services Committee. She is also a member of The University of Colorado Physical Therapy Scholarship Endowment Board and the International Council on Active Aging Advisory Board.
Matt Murphy is currently President and CEO at Griswold International LLC, one of the nation's oldest non-medical home care franchise brands. Griswold operates over 200 locations in 32 states, and has both owned and franchised locations. Prior to joining Griswold, Matt was CEO of Financial Health Services, LLC, a third party billing and revenue cycle management business that services the senior care market. Between both businesses, Matt has dedicated the last 5 years to supporting passionate business owners who are committed to helping aging and disabled adults live independently. Prior to joining FHS, Matt spent 7 years with RecruitMilitary, a company specializing in helping veterans and their spouses connect with employers, and worked on everything from business development, to leading the sales force, to the role of Chief Operating Officer. During that time the company more than doubled in employees, while revenues and net income grew by double digits every year. Before that, he served as Vice President and Chief Operating Officer at Acquisition Management Services, Inc., a company that helped companies grow by acquisition. Prior to joining AMS, Matt was an in-house attorney for the University of Pennsylvania Health System, where he supported the systems network development and corporate growth activities. During the period between his undergraduate and legal studies, Matt was a Surface Warfare Officer in the United States Navy. While in the Navy, Matt served on the USS Hepburn (FF-1055) as the Gunnery Officer, Command Information Center Officer, and ultimately as Navigator. Matt holds a Bachelor of Science degree in Applied Science and Technology from Rochester Institute of Technology, and a Juris Doctorate from the State University of New York at Buffalo.
Matthew L. Plaud is an accomplished executive with over twenty years of experience in a highly regulated environment. Currently he is the CEO of SOTIO, LLC, the North American arm of the SOTIO Group. In his three years with SOTIO, he has risen through the ranks from starting as the Director of Apheresis Network Management, to taking on all aspects of Logistics, to ultimately being promoted to the CEO of the US operation. In his time in this role he has improved staff moral while enacting major savings programs.
Before joining SOTIO, Matthew held a series of progressively responsible roles within the American Red Cross. Starting as a laboratory technician, he spent over 17 years working in different areas of the organization until ultimately completing as the interim CEO of the Massachusetts Region.
Although his career was initiated in the laboratory, Matthew has spent his time expanding his knowledge of business and management. He is a graduate of UMass with a degree in Human Resource Management (Summa Cum Laude) and then went on to Eastern Nazarene College to earn a Master’s of Science in Management. He is passionate about his work and enjoys mentoring up-and-coming staff.
Dr. Norvell Vandervall (Van) Coots is the President and CEO of Holy Cross Health and the President and CEO of the Maryland Region of Trinity Health.
Prior to joining Holy Cross Health in 2016, Dr. Coots retired from the Army as a Brigadier General, his final assignment was as Commanding General, Regional Health Command Europe, and as the Command Surgeon for the US Army Europe and 7th Army, with his headquarters located in Sembach, Germany. Previous assignments included Deputy Commanding General (Support), US Army Medical Command, and as the Assistant Surgeon General (Force Projection) of the Army, 2013-2014. From 2012-2013, Dr. Coots was deployed to combat as the Surgeon General, US Forces Afghanistan and Medical Advisor to the Commander of the International Security and Assistance Force Joint Command (NATO). From 2008- 2011, he served as the final Commander of the Walter Reed Healthcare System and Walter Reed Army Medical Center, in Washington, D.C.
Dr. Coots is a graduate of the University of Oklahoma College of Medicine. Board-certified in Dermatology, he has a Masters degree in Strategy from the Army War College. He has served around the world and has commanded at all levels, including company, clinic, hospital and medical center. Dr. Coots has received numerous awards and decorations that include the Distinguished Service Medal and the Defense Superior Service Medal. He has been awarded the Legion of Honor from France and is a member of the Order of Military Medical Merit. He has numerous civilian healthcare awards that include the Scroll of Merit of the National Medical Association. He is a member of the Alpha Phi Alpha and Sigma Pi Phi Fraternities, and is a member of the American Academy of Dermatology's Leadership Circle on Volunteerism.
Pauline Corso is Operational Vice President and Chief Operating Officer, Delaware Valley Physician Network for Nemours Children’s Health System, a role she’s held since 2015. Her responsibilities include managing a group of 380 employed physicians across 30 Delaware Valley sites including the Nemours/Alfred I. duPont Hospital for Children in Wilmington, DE. Pauline oversees new and existing partnerships and manages nearly a dozen existing external health organization pediatric partnerships throughout Delaware, Maryland, New Jersey and Pennsylvania. Pauline has been successful at growing innovative programs at Partner hospitals to keep care local. Prior to being named Chief Operating Officer, Pauline served as Physician Practice Administrator for Nemours Delaware Valley. She continues to oversee and manage all aspects of Practice Operations throughout the network.
Pauline is an active member of the American Association of Medical Colleges, Association of Academic Administrators in Pediatrics as well as the American College of Healthcare Executives. Pauline is also an active contributor to professional organizations and conferences around the nation. She has also served on the American Lung Association Mid-Atlantic Board.
Born and raised in Philadelphia, Pauline currently resides in West Deptford, NJ. She holds a Bachelor of Science Degree in Business Administration from Peirce College in Philadelphia where she received the President’s List Achievement Award in Business Administration.
Preston Brice joined MBF Healthcare Partners as a managing director in 2016 and has spent the last 10+ years focused on the healthcare services sector. Most recently he was with Apple Tree Partners (ATP), a $1.5 Bn healthcare focused venture capital/ growth equity fund. During his time at ATP, Preston served as the interim CEO and a Director of Cure Forward (precision medicine technology platform) in addition to being a Board Observer for Clean Slate Addiction Treatment Centers, TripleCare (telemedicine for SNFs) and QualDerm Partners (dermatology practices). Preston has held roles in private equity and investment banking (both M&A as well as leveraged finance) including time at The Beekman Group, a middle market private equity fund, and CIT Group, a middle market investment bank.
Preston earned his M.B.A. from Columbia Business School, where he achieved Dean’s Honors and Distinction and holds a B.S. in Business Administration from Boston University’s School of Management where he graduated magna cum laude.
MBF Healthcare Partners is a healthcare focused private equity fund specializing in strategic growth equity investments and majority recapitalizations of middle market companies. Founded by successful operating executives, we not only understand the day to day challenges of growing a business but also have deep insights into what it takes to succeed in today’s shift to value based care. We are actively looking for executives with whom to partner as we deploy our second fund. Our target initial equity check is $20MM to $50MM per deal.
Randy Oostra, DM, FACHE (62), is the President and Chief Executive
Officer of ProMedica, a non-profit, mission based health system based
in Toledo. ProMedica has more than 17,000 employees and more than
2,300 physicians with 900 healthcare providers employed by ProMedica
Physicians. Its 13 hospitals and more than 300 facilities offer comprehensive diagnostic, medical
and surgical specialties in heart and vascular, oncology, orthopedics, neurology, and women
and pediatric services. Forbes has selected ProMedica for its 2017 list of America's Best
Employers and Truven Health Analytics, part of the IBM Watson Health business, has listed
ProMedica in the top quintile for a top performing health system.
In addition to President and CEO, he has held numerous roles at ProMedica since joining the
system in 1997 including: President and Chief Operating Officer (2006 - 2009), Regional
President (2002 – 2006), and Corporate Vice President, Strategic Business Development (1998 –
2006). Prior to joining ProMedica, Randy served in myriad roles in health care leadership,
including: Saint Anthony’s Health System, Alton, Illinois (1994 – 1997); Blodgett Memorial
Medical Center, Grand Rapids, Michigan (1989 – 1994); Health One Corporation, Minneapolis,
Minnesota (1987 – 1989); and LCM, Sioux Falls, South Dakota (1982 – 1987).
Randy holds a Doctorate in Management from Case Western Reserve University; a Master’s
degree in Health Care Administration from the University of Minnesota; a Master’s degree in
Management from the University of Wisconsin; and a Bachelor of Science degree in Biology
from Northwestern College, Orange City, Iowa. Randy has been recognized by Becker’s
receiving the Healthcare Leadership Award and was named by Modern Healthcare 100 most
influential people in healthcare for 2017.
Randy’s commitment to the healthcare industry, and community, is evidenced in his extensive
involvement in numerous professional and civic organizations at the local, regional and national
levels. He is a board member of the American Hospital Association; Health Research &
Educational Trust (HRET) Board member; a member of the Ohio and Michigan Hospital
Associations; is a fellow with the American College of Healthcare Executives. He is a Board
Member of the Regional Growth Partnership, Toledo Art Museum, Northwestern College
(Iowa), the Development Committee for Bread for the World, chaired the 22 nd Century
Committee and is currently the Board Chair for the Toledo Symphony and the Downtown
Randy and his wife, Barbara, have three grown sons. In addition to spending time with his
family, Randy’s interests include running, golfing, traveling and reading.
Rick Mangat, Ph.D. has been the Chief Executive Officer and President of NOVADAQ Technologies Inc. since July 2016.
Prior to that, Rick served as Senior Vice President and General Manager of NOVADAQ. He also held positions as Vice
President of Operations and Director of NOVADAQ.
Rick Mangat co-founded NOVADAQ in April of 2000 and is a co-inventor of the SPY System. The research element of his
Ph.D. thesis (Pharmacology and Therapeutics) performed at the National Research Council of Canada (Institute for
Biodiagnostics) formed the foundation for the SPY System and related intellectual property. Rick received his B.Sc. from
the University of Toronto and his Ph.D. from the University of Manitoba.
Rusty Frantz serves as President and CEO for NextGen Healthcare (Nasdaq: QSII), a leading provider of
comprehensive solutions to the Ambulatory Physician market segment. Rusty joined NextGen in July of
Prior to joining NextGen, Rusty spent eight years in increasingly responsible roles at CareFusion Corp., a
San Diego-based global medical technology corporation that provides products and services to help
hospitals improve safety and care quality. From 2011 until March 2015, when CareFusion was acquired
by Becton, Dickinson and Company (BD), Rusty was senior vice president and general manager, global
dispensing division. The transformational medication management strategy he developed across three
global brands created $1 billion in global revenue and was a key strategic driver in the acquisition of
CareFusion by BD. Prior to heading the division, Rusty served as vice president of research and
development of the Pyxis business unit of CareFusion and also served as general manager of Pyxis
Perioperative Solutions, a leader in hospital and health system supply management solutions.
Previously, Rusty was chief technology officer and co-founder of OutPurchase, a provider of cloud-
based procurement solutions and services. He began his career as one of the first employees at
Omnicell, a leading supplier of comprehensive automation and business analytics software for patient-
centric medication and supply management across the healthcare continuum.
Rusty holds a Bachelor of Science degree in engineering from the Maine Maritime Academy and a
Master of Science degree in Engineering from Stanford University.
As chief executive officer of Magellan Healthcare, Sam Srivastava focuses on improving health and affordability through advanced analytics and clinical solutions. He leads the strategy development, operations, product development and management, and profitability and growth of Magellan Healthcare, while positioning Magellan as a leader in the behavioral health, Medicaid and specialty healthcare markets. Srivastava also provides leadership over enterprise strategy, communication and government affairs. Prior to joining Magellan, Srivastava worked at Cigna where he was president of the national and senior business segments. He had executive management responsibility for the strategic planning, business operations, growth and financial performance for these segments, which serve approximately 18 million individuals. He was instrumental in the acquisition of HealthSpring and the pharmacy benefit management partnership with CatamaranRx. Srivastava has held executive leadership positions in the commercial, senior, low-income and disabled population segments at UnitedHealth Group and HealthNet, and served as a management consultant in the United States and internationally, primarily focusing on the areas of developing and improving integrated health care delivery systems for providers, insurers and governments. Srivastava graduated from Kent State University with a bachelors degree in medical science and humanities, and completed graduate work at Yale University in healthcare management. He also sits on a number of advisory boards, including Oliver Wyman, Yale School of Public Health and Yale Healthcare Conference. He is married to Dr. Lisbet Lundsberg, a member of the faculty at the Yale School of Medicine, and resides in Wilton, Conn. with their four daughters.
Dr. Steve Allen has been CEO of Nationwide Children’s Hospital since July 2006. Dr. Allen is credited with leading the organization’s prominence as a national and international leader in pediatric healthcare and research. With more than 1 million patient visits each year, Nationwide Children’s is a global healthcare destination with children referred for treatment from all 50 states and more than 41 nations worldwide. The hospital’s outstanding medical staff is recognized for excellence in a wide range of clinical specialties and research discoveries. US News and World Report have consistently named Nationwide Children’s Hospital to their Honor Roll as one of the best children’s hospitals in America.
Prior to coming to Columbus, Steve was a physician, scientist, teacher and executive in the Texas Medical Center in Houston for 24 years. He has published over 100 articles and more than 20 book chapters on a variety of medical topics. He is board-certified in Anesthesiology and Critical Care Medicine and awarded an MBA. He serves on a number of community boards, as well as the past chair for the Children’s Hospital Association board. He is married to Dr. Jamie Allen and has five children.
Steven Krein is the CEO and co-founder of StartUp Health, which is organizing and supporting a global army of Health Transformers. StartUp Health has the world’s largest digital health portfolio at nearly 200 companies spanning 18 countries and 65+ cities.
Prior to StartUp Health, Steven co-founded and led several technology companies including OrganizedWisdom, Promotions.com and Webstakes, a global online advertising, direct marketing, and technology company, which he took public on Nasdaq and grew to a $500M market cap before it was acquired by iVillage in 2002. Steven began his online career with Law Journal Extra!, now known as Law.com, the first online legal news and information website.
Steven is a serial entrepreneur, speaker, investor, advisor and entrepreneurial coach. Steven has been a keynote speaker at events hosted by Children’s Hospital Colorado, Cleveland Clinic, Google, Johnson & Johnson, Lake Nona Institute, McKinsey, Slush and Wharton, among others and has been a guest on Bloomberg TV, CNBC, CNN, FOX Business and The Today Show.
Steven received his JD degree from Delaware Law School and BA degree from the University of Maryland, College Park. Steven is a member of YPO (Young Presidents’ Organization) Metro New York Chapter and lives in New York City with his wife and three daughters. Follow him on Twitter @stevenkrein.
Steven H. Stein, MD is the Chief Medical Officer at Incyte Corporation. In this role, Dr. Steins primary responsibility is leading all the medical and scientific activities involving clinical development, clinical operations, pharmacovigilance, clinical pharmacology, scientific communications and medical affairs at Incyte Dr. Stein previously worked at Novartis Oncology as the Senior Vice President and Head of U.S. Clinical Development and Medical Affairs and prior to that at GlaxoSmithKline as Vice President, Global Oncology, Clinical Development and also as Head of Medicines Development for Hematology and Supportive Care. Dr. Stein earned his MBBCH from the University of Witwatersrand in Johannesburg, South Africa. He has authored more than 100 scientific papers and presentations and is an Adjunct Assistant Professor in the School of Medicine, University of Pennsylvania. Dr. Stein is also an active member of several professional and scientific societies and academic committees.
Dr. Neuwirth began his career as an academic general internist with a particular focus on healthcare communication and relationship- centered care. His articles on humanism in health care have been published in medical journals as well as in the New York Times and Newsweek; and his efforts to improve healthcare delivery have also been featured in Forbes, Fast Company, WebMD, the Yale School of Management Journal, The Boston Globe and The Charlotte Observer. Zeev currently serves as Senior Medical Director of Primary Care within the Carolinas Healthcare System Medical Group a 1900 provider multi-specialty network. In addition, he is an executive leader for core strategic initiatives focused on Population Health Management, Payment Alignment, Primary & Specialty Care Redesign, Corporate Health, and Retail Medicine. Dr. Neuwirth has been deeply engaged in community health and mHealth innovations while at Carolinas. In 2012, he was selected as one of 70 participants from a pool of over 1000 applicants, into the CMMS Innovation Fellows program. In 2014, he received an Innovation in Healthcare award from the Charlotte Business Journal. He currently functions as an advisor to a number of healthcare start-ups. Prior to his current role at Carolinas, Zeev served as Chief of Clinical Effectiveness & Innovation at Harvard Vanguard Medical Associates, a 600 physician multi-specialty practice located in Eastern Massachusetts. In 2011, during his tenure at Harvard Vanguard, Zeev received the first Mayoral Award for Innovation in Healthcare from then Boston Mayor, Thomas Menino. Zeev attended Tufts University undergrad, The University of Pennsylvania School of Medicine, and completed his internship and residency in Internal Medicine at the Mount Sinai Hospital in Manhattan. In addition to his medical training, Dr. Neuwirth is a certified family and group therapist, having trained at the renowned Ackerman Institute for the Family. He holds a Masters degree in Health Care Management from the Harvard School of Public Health where he has also taught courses on health care strategy to physician executives in a Masters level program.
To Be Announced
This event starts on February 12th at 5:00 PM.
On February 12th & 13th, 2018, YJP will be hosting its CEO Healthcare Symposium. Featuring speakers from the hospital, insurance, biotech, pharma, medical device, medtech, senior living, and home care sectors, this event will bring together top executives from across the healthcare spectrum to discuss the current and future market trends that we are seeing in the industry.
The breakout sessions, featuring our signature YJP format for maximum interaction and value, will focus on topics such as:
-The Future of Post-Acute Care
-Investing in Healthcare
-Positioning Your Organization for the Future
-Advances in Immuno-Oncology
-Transitioning to Value-Based Care
...and many more!
Join us for two days of stimulating conversation, gourmet food and drink, and high-level networking with the top names in healthcare.